معرفی
Dr. Saad Hannan is a prominent Research Fellow at Harvard University's Department of Molecular and Cellular Biology and Center for Brain Science. He is affiliated with the Conte Center at Harvard and F.M. Kirby Neurobiology Center at Boston Children’s Hospital. His research focuses on GABAergic signaling mechanisms in neurodevelopmental disorders, utilizing electrophysiology, cellular imaging, and behavioral approaches to investigate biological and clinical questions.
Dr. Hannan graduated with a First Class degree from University College London before completing his PhD as a Dorothy Hodgkin Postgraduate Scholar. He has held prestigious fellowships such as the Rosetrees Trust Postdoctoral Award, International Rett Syndrome Foundation Fellowship, and Wellcome Trust ISSF Fellowship. His work contributes to understanding how interneurons develop and shape behavior during critical brain development stages.
- 2025: Brain (2 articles)
- 2023: Neuropharmacology
- 2022: Science Signaling
- 2021: eLife, Preprint
- 2020: Journal of Neuroscience, Neuropharmacology
- 2018: Journal of Biological Chemistry, Cell Reports
- 2017: Nature Communications
- 2016: Cell Reports
- 2015: Neuropharmacology, Stem Cells
- 2014: Nature Communications
- 2013: Methods in Enzymology
His research spans synaptic plasticity, inhibitory neurotransmission, and GABA receptor dynamics, with recent studies exploring allosteric modulation and phosphorylation mechanisms in epilepsy and neurodevelopmental disorders. Dr. Hannan's work has been recognized through multiple fellowships and collaborations within a London-based consortium studying GABA inhibition in Down syndrome.
Dr. Hannan is actively involved in the Hensch Laboratory at Harvard, a hub for exploring critical period plasticity and its implications for developmental disorders. The lab is part of the Conte Center, an interdisciplinary initiative funded by the National Institute of Mental Health, and maintains strong ties with Boston Children’s Hospital.
